WAKE UP ?? What the fuk is wrong with this market ?? AgeX Therapeutics are a preclinical stage pluri stem cell developer much like Hemostemix, market cap of 33 mil $s. They are 4 years behind Hemostemix in their pipeline development stage, who are very very likely to be pushing a Phase III once data is released. Accudata had their mid point analysis remanded by the Delaware courts, meaning that data is in lock and key and upon settlement to be released back to Hem. Hemostemix had Aspire by the balls, they have not only documented Jacobs, ex-CMO of Hemostemix acting on behalf of the company after transitioning to Aspire, to poach CRO relations and the data the company had farmed for clinical trials, but also have detailed evidence of Makofka et al, hacking the Hemostemix data base and financial records 80+ times after exiting the company with a fraudulent ALA that required board approval but was only assigned a signatore by transitory acting CEO Angus Jenkins, who just coincidentally happened to register a Delaware shell on the same day J Wood registered one of his own out in the same state. Coincidence? Or money laundering as a payment for services rendered? add the pieces will you. Not only that, but Hem has documentation that Makofka and Aspire executives were forwarding Hem denominated email addresses to their Aspire domains, while pretending to act on behalf of the company in engageing clinical trial organisations running ACP-01. Hemostemix had Aspire by the fking balls. If you think that the settlement is in any way unfavourable to Hem, you have lost your fuking marbles. Wake the fuk up people. Hemostemix 17 mil $ market cap? really ?????? Pluristem at 65 mil market cap are running allogenic therapies that have all sorts of host rejection complications, and do not even have a Diabetes pipeline, 460 million people worldwide, do the math. How about you try a 100 mil market cap and we can start talking, yea.